Abstract
The family Paramyxoviridae contains three genera: paramyxoviruses, morbilliviruses, and pneumoviruses(1) (Table I). They infect a large variety of mammals and birds, but the strains are very host specific. Classification in separate genera is based on differences in hemagglutinating and neuramini dase activities, as well as in morphology. The Paramyxovirus genus includes the human pathogens, mumps virus, parainfluenza virus types 1–4, and several animal pathogens, of which Sendai virus of mice, simian virus 5 (SV5) of monkey, and Newcastle disease virus (NDV) of birds are the best characterized. The genus Morbillivirus includes measles virus (MV) and three nonhuman viruses, canine distemper virus (CDV), rinderpest virus (RPV), and peste des petits ruminants virus (PPRV). Measles virus is not included in this review, because it has been presented in Chapter 18. Respiratory syncytial virus (RSV), bovine respiratory syncytial virus, and pneumonia virus of mice are members of the genus Pneumovirus. Throughout this chapter, the term paramyxoviruses) is used to describe the whole family Paramyxoviridae.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kingsbury, D. W., M. A. Bratt, P. W. Choppin, R. P. Hanson, Y. Hosaka, V. ter Meulen, E. Norrby, W. Plowright, R. Rott, and W. H. Wunner, Paramyxoviridae, Intervirology 10:137–151 (1983).
Portner, A., The HN glycoprotein of Sendai virus: Analysis of site(s) involved in hemag-glutinating and neuraminidase activities, Virology 115:375–384 (1981).
Yewdell, J., and W. Gerhard, Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities, J. Immu nol. 128:2670–2675 (1982).
Örvell, C., and E. Norrby, Immunologic properties of purified Sendai virus glycoproteins, J. Immunol. 119:1882–1887 (1977).
Blumberg, B., C. Giorgi, L. Roux, R. Raju, P. Dowling, A. Chollet, and D. Kolakofsky. Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins, Cell 41:269–278 (1985).
Hiebert, S. W., R. G. Paterson, and R. A. Lamb, Hemagglutinin neuraminidase protein of the paramyxovirus simian virus 5: Nucleotide sequence of the mRNA predicts an N-terminal membrane anchor, J. Virol. 53:1–6 (1985).
Örvell, C., and M. Grandien, The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus, J. Immunol. 129:2779–2787 (1982).
Wertz, G. W., P. L. Collins, Y. Huang, C. Gruber, S. Levine, and L. A. Ball, Nucleotide sequence of the G protein gene of human respiratory syncytial reveals an unusual type of viral membrane protein, Proc. Natl. Acad. Sci. USA 82:4075–4079 (1985).
Elango, N., J. E. Copligan, R. C. Jambou, and S. Venkatesan, Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: Nucleotide sequence of mRNA and limited amino acid sequence of the purified protein, J. Virol. 57:481–489 (1986).
Markwell, M. K., and C. F. Fox, Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking, J. Virol. 33:152–166 (1980).
Löve, A., R. Rydbeck, G. Utter, C. Örvell, K. Kristensson, and E. Norrby. Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoen cephalitis, J. Virol. 58:220–222 (1986).
Merz, D. C., A. C. Server, M. N. Waxham, and J. S. Wolinsky, Biosynthesis of mumps virus F glycoprotein: Non-fusing strains efficiently cleave the F glycoprotein precursor, J. Gen. Virol. 64:1457–1467 (1983).
Paterson, R. G., T. J. R. Harris, and R. A. Lamb, Fusion protein of the paramyxovirus SV5: Nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein, Proc. Natl. Acad. Sci. USA 81:6706–6710 (1984).
Jambou, R. C., N. Elango, and S. Venkatesan, Proteins associated with human parainfluenza virus type 3, J. Virol. 56:298–302 (1985).
Rozenblatt, S., O. Eizenberg, R. Ben-Levy, V. Lavie, and W. J. Bellini, Sequence homology within the morbilliviruses, J. Virol. 53:684–690 (1985).
Galinsky, M. S., M. A. Mink, D. M. Lambert, S. L. Wechsler, and M. W. Pons, Molecular cloning and sequence analysis of the human parainfluenza 3 virus RNA encoding the nucleocapsid protein, Virology 149:139–151 (1986).
Buetti, E., and P. V. Choppin, The transcriptase complex of the Paramyxovirus SV5, Virology 82:493–508 (1977).
Mottet, G., A. Portner, and L. Roux, Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and Fo glycoproteins, J. Virol.. 59:132–141 (1986).
Waxham, M. N., D. C. Merz, and J. S. Wolinsky, Intracellular maturation of mumps virus hemagglutinin-neuraminidase glycoprotein: Conformational changes detected with monoclonal antibodies, J. Virol. 59:392–400 (1986).
Prince, G. A., A. B. Jenson, R. L. Horswood, E. Camargo, and R. M. Chanock. The pathogenesis of respiratory syncytial virus infection in cotton rats, Am. J. Pathol. 93:771 -783 (1978).
Prince, G. A., R. L. Horswood, E. Camargo, D. Koening, and R. M. Chanock. Mechanism of immunity to respiratory syncytial virus in cotton rats, Infect. Immun. 42:81–87 (1983).
Prince, G. A., R. L. Horswood, and R. M. Chanock, Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats, J. Virol. 55:517–520 (1985).
Walsh, E. E., J. J. Schlesinger, and M. W. Brandriss, Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies, Infect. Immun. 43:765–758 (1984).
Yanagihara, R. and K. Mcintosh. Secretory immunological response in infants and children to parainfluenza virus types 1 and 2, Infect. Immun. 30:23–28 (1980).
Mcintosh, K., H. B. Masters, I. Orr, R. K. Chao, and R. M. Barkin, The immunologic response to infection with respiratory syncytial virus in infants, J. Infect. Dis. 138:24–32 (1978).
Kaul, T. N., R. C. Welliver, and P. L. Ogra, Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infec tion with respiratory syncytial virus, J. Med. Virol. 9:149–158 (1982).
Mcintosh, K., Interferon in nasal secretions from infants with viral respiratory tract infections, J. Pediatr. 93:33–36 (1978).
Hall, C. B., R. G. Douglas, R. L. Simons, and J. M. Geiman, Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections, J. Pediatr. 93:28–32 (1978).
Meurman, O., O. Ruuskanen, H. Sarkkinen, P. Hänninen, and P. Halonen, Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay, J. Med. Virol. 14:67–72 (1984).
Welliver, R. C., T. N. Kaul, T. I. Putnam, M. Sun, B. S. Riddlesberger, and P. L. Ogra, The antibody response to primary and secondary infection with respiratory syncytial virus: Kinetics of class-specific responses, J. Pediatr. 96:808–813 (1980).
Scott, R., M. Scott, and G. L. Toms, Cellular and antibody response to respiratory syncytial (RS) virus in human colostrum, maternal blood, and cord blood, J. Med. Virol. 8:55– 66 (1981).
Vainionpää, R., O. Meurman, and H. Sarkkinen, Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection, /. Virol. 53:976–979 (1985).
Ward, K. A., P. R. Lambden, M. M. Ogilvie, and P. J. Watt. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection, /. Gen. Virol. 64:1867–1876 (1983).
Kasel, J. A., A. L. Fran, W. A. Keitel, L. H. Taber, and W. P. Glezen, Acquistion of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children,J. Virol. 52:828–832 (1984).
Fernald, G. W., J. R. Almond, and F. W. Henderson. Cellular and humoral immunity in recurrent respiratory syncytial virus infections, Pediatr. Res. 17:753–758 (1983).
Cranage, M. P., and P. S. Gardner, Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections, J. Med. Virol. 5:161–170 (1980).
Welliver, R. C., T. N. Kaul, M. Sun, and P. L. Ogra, Defective regulation of immune responses in respiratory syncytial virus infection, J. Immunol. 133:1925–1930 (1984).
Domurat, F., N. J. Roberts, Jr, E. E. Walsh, and R. Dagan, Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo, J. Infect. Dis. 152:895–902 (1985).
Kupers, T. A., J. M. Petrich, A. W. Holloway, and J. W. Geme, Jr., Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus, J. Pediatr. 76:716–721 (1970).
Hall, C. B., and F. S. Kantor. Depression of established delayed hypersensitivity by mumps virus, J. Immunol. 108:81–85 (1972).
Chiba, Y., K. Horino, M. Umetsu, Y. Wataya, S. Chiba, and T. Nakao, Virus excretion and antibody response in saliva in natural mumps, Tohoku J. Exp. Med. 111:229–238 (1973).
Ukkonen, P., M-L. Granström, and K. Penttinen, Mumps-specific immunoglobulin M and G antibodies in natural mumps infection as measured by enzyme-linked immunosorbent assay, J. Med. Virol. 8:131–142 (1981).
Ukkonen, P., M-L. Granström, J. Räsänen, E-M. Salonen, and K. Penttinen, Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients, J. Med. Virol. 8:257–265 (1981).
Fryden, A., H. Link, and E. Norrby, Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology, Infect. Immun. 21:852–861 (1978).
Copelovici, Y., D. Strulovici, A. L. Cristea, V. Tudor, and V. Armasu, Data on the efficiency of specific anti mumps immunoglobulins in the prevention of mumps and of its complications, Rev. Roum. Med. Virol. 30:171–177 (1979).
Ilonen, J., Lymphocyte blast transformation response of seropositive and seroegative subjects to herpes simplex, rubella, mumps and measles virus antigens, Acta Pathol. Micro biol. Scand. Sect. C 87:151–157 (1979).
Ilonen, J., A. Salmi, K. Penttinen, and E. Herva, Lymphocyte blast transformation and antibody response after vaccination with inactivated mumps virus vaccine, Acta Pathol. Microbiol. Scand. Sect. C 89:303–309 (1981).
Fryden, A., H. Link, and E. Möller, Demonstration of cerebrospinal fluid lymphocytes sensitized against virus antigens in mumps meningitis, Acta Neurol. Scand. 57:396–404 (1978).
Kreth, H. W., L. Kress, H. G. Kress, H. F. Ott, and G. Eckert, Demonstration of primary cytotoxic T cells in venous blood and cerebrospinal fluid of children with mumps meningitis, J. Immunol. 128:2411–2415 (1982).
Kress, H. G., and H. W. Kreth, HLA restriction of secondary mumps-specific cytotoxic T lymphocytes, J. Immunol. 129:844–849 (1982).
Tsutsumi, H., Y. Chiba, W. Abo, S. Chiba, and T. Nakao, T-cell-mediated cytotoxic response to mumps virus in humans, Infect. Immun. 30:129–134 (1980).
Roberts, Jr., N. J., A. H. Prill, and T. N. Mann, Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus, J. Exp. Med. 163:511–519 (1986).
Borysiewicz, L. K., P. Casali, B. Rogers, S. Morris, and J. G. P. Sissons, The immunosuppressive effects of measles virus on T cell function-Failure to affect IL-2 release of cytotoxic T cell activity in vitro, Clin. Exp. Immunol. 59:29–36 (1985).
Roberts, N. J., Jr., Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages, Infect. Immun. 35:1142–1146 (1982).
Nakayama, T., Immune-specific production of gamma interferon in human lymphocyte cultures in response to mumps virus, Infect. Immun. 40:486–492 (1983).
Dunnick, J. K., and G. J. Galasso, Clinical trials with exogenous interferon: Summary of a meeting, J. Infect. Dis. 139:109–123 (1979).
Aderka, D., H. Holtmann, L. Toker, T. Hahn, D. Wallach. Tumor necrosis factor induction by Sendai virus, J. Immunol. 136:2938–2942 (1986).
Brenan, M., and R. M. Zinkernagel, Influence of one virus infection on a second concurrent primary in vivo antiviral cytotoxic T-cell response, Infect. Immun. 41:470–475 (1983).
Scott, R., M. O. De Landazuri, P. S. Gardner, and J. J. T. Owen, Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus, Clin. Exp. Immunol. 28:19–26 (1977).
Cranage, M. P., P. S. Gardner, and K. Mcintosh, In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions, Clin. Exp. Immunol. 43:28–35 (1981).
Kaul, T. N., R. C. Welliver, and P. L. Ogra, Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus, Infect. Immun. 37:492–498 (1982).
Meguro, H., M. Kervina, and P. F. Wright, Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: Characterization of in vitro and in vivo properties, J. Immunol. 122:2521–2526 (1979).
Alsheikhly, A. R., B. Wahlin, T. Andersson, and P. Perlmann, Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro, J. Immunol. 132:2760–2766 (1984).
Alsheikhly, A., C. Örvell, B. Härfast, T. Andersson, P. Perlmann, and E. Norrby, Sendai-virus-induced cell-mediated cytotoxicity in vitro, Scand. J. Immunol. 17:129–138 (1983).
Alsheikhly, A-R, T. Andersson, and P. Perlmann, Virus-mediated induction in human lymphocytes of antibody-independent cytotoxicity (ADCC) against natural killer-resistant tumor target cells, Cell Immunol 88:511–520 (1984).
Alsheikhly, A. R., C. Örvell, T. Andersson, and P. Perlmann, The role of serologically defined epitopes on mumps virus HN-glycoprotein in the induction of virus-dependent cell-mediated cytotoxicity, Scand. J. Immunol. 22:529–538 (1985).
Härfast, B., T. Andersson, V. Stejskal, and P. Perlmann, Interactions between human lymphocytes and paramyxovirus-infected cells: Adsorption and cytotoxicity, J. Immunol. 118:1132–1137 (1977).
Welsh, R., and L. A. Hallenbek, Effect of virus infections on target cell susceptibility to natural killer cell-mediated lysis, J. Immunol. 124:2491–2497 (1980).
Andersson, L. J., J. C. Hierholzer, C. Tsou, R. M. Hendry, B. F. Fernie, Y. Stone, and K. Mcintosh. Antigenic characterization of respiratory syncytial virus strains with mono clonal antibodies, J. Infect. Dis. 151:626–633 (1985).
Mufson, M. A., C. Örvell, B. Rafnar, and E. Norrby, Two distinct subtypes of human respiratory syncytial virus, J. Gen. Virol. 66:2111–2124 (1985).
Welliver, R. C., D. T. Wong, M. Sun, B. S. Middleton, Jr., R. S. Vaughan, and P. L. Ogra, The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after incubation, N. Engl. J. Med. 15:841–846 (1981).
Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, and R. H. Parrott, Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, Am. J. Epidemiol. 89:422–434 (1969).
Fulginiti, V. A., J. J. Eller, O. F. Sieber, J. W. Joyner, M. Minamitani, and G. Meiklejohn, Respiratory virus immunization. I. A. field trial of two inactivated respiratoy virus vaccines: An aqueous trivalent parainfluenza virus vaccine and an alumprecipitated respiratory syncytial virus vaccine, Am. J. Epidemiol. 89:435–448 (1967).
Chin, J., R. L. Magoffin, L. A. Shearer, J. H. Schieble, and E. H. Lennette, Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population, Am. J. Epidemiol. 89:449–463 (1969).
Penttinen, K., E-P. Helle, and E. Norrby, Differences in antibody response induced by formaldehyde inactivated and live mumps vaccines, Dev. Biol. St. 43:265–268 (1979).
Murphy, B. R., G. A. Prince, E. E. Walsh, H. W. Kim, R. H. Parrott, V. G. Hemming, W.J. Rodriguez, and R. M. Chanock, Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine, J. Clin. Microbiol. 24:197–202 (1986).
Norrby, E., G. Enders-Ruckle, and V. ter Meulen, Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus, J. Infect. Dis. 132:262–269 (1975).
Prince, G. A., A. B. Jenson, V. G. Hemming, B. R. Murphy, E. E. Walsh, R. L. Horswood, and R. M. Chanock, Enchancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus, /. Virol. 57:721–728 (1986).
Elango, N., G. A. Prince, B. R. Murphy, S. Venkatesan, R. M. Chanock, and B. Moss, Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein, Proc. Natl. Acad. Sci. USA 83:1906–1910 (1986).
Appel, M. J. G., Reversion to virulence of attenuated canine distemper virus in vivo and in vitro, J. Gen. Virol. 41:385–393 (1978).
Rossiter, P. B., and R. C. Wardley, The differential growth of virulent and avirulent strains of rinderpest virus in bovine lymphocytes and macrophages, J. Gen. Virol. 66:969– 975 (1985).
Due-Nguyen, H., and W. Henle, Replication of mumps virus in human leukocyte cultures, J. Bacteol. 92:258–265 (1966).
Fleischer, B., and H. W. Kreth, Mumps virus replication in human lymphoid cell lines and in peripheral blood lymphocytes: Preference for T cells, Infect. Immun. 35:25–31 (1982).
Mangi, R. J., T. P. Munyer, S. Krakowka, R. O. Jacoby, and F. S. Kantor, A canine distemper model of virus-induced anergy,y. Infect. Dis. 133:556–563 (1976).
Kauffman, C. A., A. G. Bergman, and R. P. O’Connor, Distemper virus infection in ferrets: An animal model of immunosuppression, Clin. Exp. Immunol. 67:617–625 (1982).
Kaul, T. N., H. Faden, and P. L. Ogra, Effects of respiratory syncytial virus and virus-antibody complexes on the oxidative metabolism of human neutrophils, Infect. Immun. 32:649–654 (1981).
Smith, T. F., K. Mcintosh, M. Fishaut, and P. M. Henson. Activation of complement by cells infected with respiratory syncytial virus, Infect. Immun. 33:43–48 (1981).
Jakab, G. J., and G. A. Warr, Immune-enhanced phagocytic dysfunction in pulmonary macrophages infected with parainfluenza 1 (Sendai) virus1-3, Am. Rev. Respir. Dis. 124:575–581 (1981).
Silverberg, B. A.,G. J. Jakab, R. G. Thompson, G. A. Warr, and K. S. Boo, Ultrastructural alterations in phagocytic functions of alveolar macrophages after parainfluenza virus infection, J. Reticuloendothel. Soc. 25:405–416 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Vainionpää, R., Hyypiä, T. (1989). Paramyxoviruses. In: Specter, S., Bendinelli, M., Friedman, H. (eds) Virus-Induced Immunosuppression. Infectious agents and pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5583-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5583-0_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5585-4
Online ISBN: 978-1-4684-5583-0
eBook Packages: Springer Book Archive